Cargando…

Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model

Arazyme, a metalloprotease from the spider Nephila clavata, exerts hepatoprotective activity in CCL(4)-induced acute hepatic injury. This study investigated the hepatoprotective effects in high-fat diet (HFD)-induced non-alcoholic fatty liver disease-like C57BL/6J mice. The mice were randomly divide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hua, Yoo, Wonbeak, Park, Hye-Mi, Lim, Soo-Youn, Shin, Dong-Ha, Kim, Seokho, Park, Ho-Yong, Jeong, Tae-Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539878/ https://www.ncbi.nlm.nih.gov/pubmed/31083413 http://dx.doi.org/10.3390/ijms20092325

Ejemplares similares

Combination Treatment of Arazyme and Soy Leaf Extract Attenuates Hyperglycemia and Hepatic Steatosis in High-Fat Diet-Fed C57BL/6J Mice
por: Lee, Hwa, et al.
Publicado: (2021)

Development of a novel denture care agent with highly active enzyme, arazyme
por: Kim, Jong-Hoon, et al.
Publicado: (2021)

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
por: Yoo, Wonbeak, et al.
Publicado: (2017)

Enzyme Feed Additive with Arazyme Improve Growth Performance, Meat Quality, and Gut Microbiome of Pigs
por: Kim, Jong-Hoon, et al.
Publicado: (2023)

Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice
por: Wollman, Ayala, et al.
Publicado: (2019)

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
por: Ju, Linling, et al.
Publicado: (2020)

Steatosis and Steatohepatitis: Complex Disorders
por: Bettermann, Kira, et al.
Publicado: (2014)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
por: Yoo, Wonbeak, et al.
Publicado: (2023)

Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model
por: Hamada, Shintaro, et al.
Publicado: (2022)

Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice
por: Park, Mi-Young, et al.
Publicado: (2013)

Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
por: Cataldi, Mauro, et al.
Publicado: (2021)

Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice
por: Park, Han-Sol, et al.
Publicado: (2016)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
por: Ganjooei, Narges Ashraf, et al.
Publicado: (2021)

Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway
por: Lee, Mi Rim, et al.
Publicado: (2020)

Protective Function of Mitogen‐Activated Protein Kinase Phosphatase 5 in Aging‐ and Diet‐Induced Hepatic Steatosis and Steatohepatitis
por: Tang, Peng, et al.
Publicado: (2019)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kim, Jeong Woo, et al.
Publicado: (2020)

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
por: Pastori, Daniele, et al.
Publicado: (2015)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
por: Sánchez-Quevedo, Janet, et al.
Publicado: (2022)

Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice
por: Ganz, Michal, et al.
Publicado: (2015)

Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
por: Porteiro, Begoña, et al.
Publicado: (2017)

A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy: an in-silico analysis
por: Mehrab, Rezvan, et al.
Publicado: (2023)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Clitorin ameliorates western diet-induced hepatic steatosis by regulating lipogenesis and fatty acid oxidation in vivo and in vitro
por: Cominguez, Divina C., et al.
Publicado: (2022)

Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
por: Kim, Jimin, et al.
Publicado: (2021)

Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model
por: Xiao, Jia, et al.
Publicado: (2014)

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
por: Akbari, Rasoul, et al.
Publicado: (2021)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis
por: Vulf, Maria, et al.
Publicado: (2021)

Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy
por: Ji, Guiyuan, et al.
Publicado: (2015)

MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis
por: Palladini, Giuseppina, et al.
Publicado: (2022)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome
por: Yang, Gabsik, et al.
Publicado: (2020)

Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model
por: Choi, Naeun, et al.
Publicado: (2019)

A Natural Bacterial-Derived Product, the Metalloprotease Arazyme, Inhibits Metastatic Murine Melanoma by Inducing MMP-8 Cross-Reactive Antibodies
por: Pereira, Felipe V., et al.
Publicado: (2014)

Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
por: Akter, Sharmin
Publicado: (2022)

Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis
por: Petrelli, Fausto, et al.
Publicado: (2022)

Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis
por: Yokomori, Hiroaki, et al.
Publicado: (2020)

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
por: Ahn, Jem Ma, et al.
Publicado: (2016)

Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice
por: Park, Na Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q8kjno25k9h0c31e2pa58i3vir